Clene Inc. (CLNN)
NASDAQ: CLNN
· Real-Time Price · USD
5.88
0.00 (0.09%)
At close: Sep 26, 2025, 3:59 PM
5.88
0.00%
After-hours: Sep 26, 2025, 05:35 PM EDT
Clene Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 64K | 64K | 65K | 64K | 44K | 143K | 65K | 226K | 64K | 189K | 130K | 2K | 7K | 170K | 63K | 138K | 199K |
| Product Revenue Growth | 0.00% | -1.54% | +1.56% | +45.45% | -69.23% | +120.00% | -71.24% | +253.12% | -66.14% | +45.38% | +6400.00% | -71.43% | -95.88% | +169.84% | -54.35% | -30.65% | n/a |
| Royalty Revenue | 17K | 27K | 22K | 27K | 29K | 27K | 43K | 43K | 43K | 44K | 44K | 33K | 23K | 29K | 47K | 63K | 14K |
| Royalty Revenue Growth | -37.04% | +22.73% | -18.52% | -6.90% | +7.41% | -37.21% | 0.00% | 0.00% | -2.27% | 0.00% | +33.33% | +43.48% | -20.69% | -38.30% | -25.40% | +350.00% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.19M | 2.66M | 2.7M | 3.41M | 3.31M | 3.42M | 3.32M | 3.67M | 3.46M | 3.18M | 4.26M | 3.34M | 4.19M | 4.38M | 2.07M | 4.4M | 6.95M | 5.39M | 1.53M | 1.79M | 1.02M | 812K | 1.4M | 2.7M | 1.34M | 1.34M |
| Selling, General, and Administrative Revenue Growth | -17.43% | -1.56% | -20.95% | +2.99% | -3.10% | +2.95% | -9.38% | +5.80% | +8.96% | -25.30% | +27.46% | -20.31% | -4.21% | +110.95% | -52.86% | -36.68% | +28.92% | +252.75% | -14.87% | +76.67% | +25.12% | -42.04% | -48.05% | +101.95% | 0.00% | n/a |
| Research and Development Revenue | 3.51M | 1.48M | 5.57M | 4.47M | 4.15M | 5.51M | 6.32M | 5.97M | 6.62M | 7.39M | 7.77M | 6.4M | 9.17M | 8.58M | 9.52M | 6.15M | 6.47M | 6.28M | 4.45M | 3.99M | 3.55M | 3.2M | 2.95M | 2.48M | 2.07M | 2.07M |
| Research and Development Revenue Growth | +137.27% | -73.40% | +24.54% | +7.73% | -24.75% | -12.71% | +5.79% | -9.72% | -10.55% | -4.84% | +21.36% | -30.14% | +6.83% | -9.90% | +54.95% | -5.04% | +3.14% | +40.88% | +11.52% | +12.38% | +10.99% | +8.43% | +19.12% | +20.02% | 0.00% | n/a |